Zain Khalpey: Secondary Stroke Prevention as The Most Important Opportunity to Reduce Disability
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on LinkedIn about a recent article by Karen L. Furie and Peter J. Kelly, published in NEJM:
”Secondary prevention remains one of the most important opportunities to reduce long term disability after ischemic stroke.
A recent review in the New England Journal of Medicine emphasizes that lowering recurrence risk depends on identifying the underlying stroke mechanism and aggressively targeting modifiable risk factors early.
Effective care extends beyond the acute event.
Early diagnostic evaluation, timely initiation of preventive therapies, and ongoing monitoring of blood pressure, rhythm disorders, lifestyle factors, and medication adherence are central to reducing recurrent stroke risk.
The focus is increasingly shifting toward structured longitudinal care, combining mechanism specific treatment with continuous risk assessment to improve outcomes after stroke.”
Title: Secondary Prevention after Ischemic Stroke
Authors: Karen L. Furie, Peter J. Kelly
Read the Full Article on NEJM
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day